In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: Effect of mitogen and cytokine stimulation

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 452-460

  Higashi, Y ^a   Turzanski, J ^a   Pallis, M ^a,b   Russell, N H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Anti red blood cell autoantibodies; Autoimmune haemolytic anaemia; T helper 1 2 cytokines

Indexed keywords

ERYTHROCYTE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; MITOGENIC AGENT; TRANSFORMING GROWTH FACTOR;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNOPATHOGENESIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE;

ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODY FORMATION; AUTOANTIBODIES; BINDING, COMPETITIVE; CASE-CONTROL STUDIES; CELLS, CULTURED; CYTOKINES; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MALE; MIDDLE AGED; MITOGENS; MULTIVARIATE ANALYSIS; RECOMBINANT PROTEINS; STIMULATION, CHEMICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034535742     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02380.x     Document Type: Article

References (32)

1. Immunomodulation of murine experimental SLE-like disease by interferon-gamma
2. In vitro immunoglobulin synthesis: T-cell requirement in pokeweed and staphylococcus aureus B-cell activation
3. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients
4. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells of HIV-1-negative intravenous drug users
5. Immunomodulatory properties of interferon-gamma. An update
6. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis
7. Altered response to and production of TGF-beta by cells from autoimmune NZB mice
8. Lymphocyte activation and cytokine production in autoimmune haemolytic anaemia (AIHA)
9. High cytokine serum levels in patients with autoimmune haemolytic anaemia (AIHA)
10. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus
11. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kD B cell growth factor, interleukin-4 and transforming growth factor-beta
12. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus
13. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-gamma-secreting cells in peripheral blood
14. Study of in vitro red cell autoantibody production in normal donors and in patients with autoimmune hemolytic anemia
15. Decreased production of interleukin-12 and other cytokines in patients with recent-onset systemic lupus erythematosus
16. Interleukin-2 is indispensable for development of immunological self-tolerance
17. Impaired production of IL-12 in systemic lupus erythematosus. Excessive production of IL-10 suppresses production of IL-12 monocytes
18. Impaired production of IL-12 in systemic lupus erythematosus. IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE
19. Immunomodulating activity of RU 41740: In vitro and in vivo studies on human lymphocytes
20. Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune haemolytic anaemia in anti-erythrocyte autoantibody-transgenic mice
21. Involvement of IL-10 in induction of autoimmmune haemolytic anaemia in anti-erythrocyte Ig transgenic mice
22. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus
23. Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis
24. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β
25. High levels of cytokines gene expression in systemic lupus erythematosus
26. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells
27. Regulatory T cells in the control of autoimmunity: The essential role of transforming growth factor β and interleukin-4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC- cells and CD4+CD8-thymocytes
28. T-helper 1 dominated responses to erythrocyte band 3 in NZB mice
29. Analysis of the cellular infiltrates and expression of cytokine in synovial tissue from patients with rheumatoid arthritis and reactive arthritis
30. Imbalance towards Th-1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice
31. Th-1 (IL-2, interferon-gamma (IFN-gamma) and Th-2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erithematosus (SLE)